SCHEMBL5827979

SCHEMBL5827979

C[S+](C)c1ccccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
CA2 P00918 4/20 0.47
TDP1 Q9NUW8 3/20 0.47
ALOX15 P16050 3/20 0.47
LMNA P02545 3/20 0.47
NPC1 O15118 3/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 3/20 0.47
EGFR P00533 2/20 0.47
FYN P06241 2/20 0.47
MMP9 P14780 2/20 0.47
RECQL P46063 2/20 0.47
KDM4E B2RXH2 2/20 0.47
MAPT P10636 2/20 0.47
CA4 P22748 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CA12 O43570 1/20 0.47
GMNN O75496 1/20 0.47
POLB P06746 1/20 0.47
CA3 P07451 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3295090 0.97 ALDH1A1 (0.45) ALDH1A1CA2TDP1ALOX15LMNA
SCHEMBL8520822 0.84 ALDH1A1 (0.52) ALDH1A1CA2TDP1ALOX15LMNA
SCHEMBL9324575 0.83 ALDH1A1 (0.33) ALDH1A1CA2TDP1ALOX15LMNA
Hydrochloric Acid SCHEMBL8853511 0.82 ALDH1A1 (0.50) ALDH1A1CA2TDP1ALOX15LMNA
SCHEMBL10434904 0.80 HSD11B1 (0.36) ALDH1A1CA2TDP1ALOX15LMNA
SCHEMBL2665742 0.79 ALDH1A1 (0.43) ALDH1A1CA2TDP1ALOX15LMNA
SCHEMBL3212125 0.77 ALDH1A1 (0.53) ALDH1A1CA2TDP1ALOX15LMNA
SCHEMBL31005126 0.77 ALDH1A1 (0.53) ALDH1A1CA2TDP1ALOX15LMNA
Bromide SCHEMBL11136419 0.74 ALDH1A1 (0.50) ALDH1A1CA2TDP1ALOX15LMNA
Hydrochloric Acid SCHEMBL9321074 0.74 ALDH1A1 (0.50) ALDH1A1CA2TDP1ALOX15LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0553737-B1 Radiation-sensitive composition BASF AG (DE) 1999-09-22 EP claimed
US-20250206970-A1 INK COMPOSITION, LIGHT-BLOCKING MEMBER AND IMAGE DISPLAY DEVICE NATOCO CO., LTD. (JP) 2025-06-26 US disclosed
US-6991888-B2 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds AZ ELECTRONIC MATERIALS USA CORP. (US) 2006-01-31 US disclosed
EP-1516229-A2 PHOTORESIST COMPOSITION FOR DEEP ULTRAVIOLET LITHOGRAPHY COMPRISING A MIXTURE OF PHOTOACTIVE COMPOUNDS AZ Electronic Materials USA Corp. (US) 2005-03-23 EP disclosed
US-20030235782-A1 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds MERCK PATENT GMBH (DE) 2003-12-25 US disclosed
US-20030235775-A1 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds CLARIANT INTERNATIONAL LTD (CH) 2003-12-25 US disclosed
WO-2003107093-A2 PHOTORESIST COMPOSITION FOR DEEP ULTRAVIOLET LITHOGRAPHY COMPRISING A MIXTURE OF PHOTOACTIVE COMPOUNDS CLARIANT INTERNATIONAL LTD (CH) 2003-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030235782-A1 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds SUN2, UROD, ERCC1 ALDH1A1 2510/4885CA2 312/4885TDP1 952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.